Insulindysregulation – eine Zivilisationserkrankung und ihre Folgen

Die Insulindysregulation, wie sie beispielsweise im Rahmen des Equinen Metabolischen Syndroms (EMS) zu beobachten ist, ist eine Zivilisationserkrankung, die immer mehr Pferde betrifft. Da das klinische Bild insbesondere im frühen Stadium vielfältig sein kann, spielt die Diagnostik eine sehr wichtige Rolle. Erfahren Sie hier, welche Tests bei welchen Patienten sinnvoll sind und welche Therapiemöglichkeiten zur Verfügung stehen.

Publication History

Article published online:
12 September 2024

• Literatur

• 1 de Laat MA, McGree JM, Sillence MN. Equine hyperinsulinemia: investigation of the enteroinsular axis during insulin dysregulation. Am J Physiol Endocrinol Metab 2016; 310 (01) E61-E72
• 2 Bamford NJ, Potter SJ, Baskerville CL. et al. Effect of increased adiposity on insulin sensitivity and adipokine concentrations in different equine breeds adapted to cereal-rich or fat-rich meals. Vet J 2016; 214: 14-20
• 3 Toth F, Frank N, Martin-Jimenez T. et al. Measurement of C-peptide concentrations and responses to somatostatin, glucose infusion, and insulin resistance in horses. Equine Vet J 2010; 42 (02) 149-155
• 4 de Laat MA, Sillence MN, McGowan CM, Pollitt CC. Continuous intravenous infusion of glucose induces endogenous hyperinsulinaemia and lamellar histopathology in Standardbred horses. Vet J 2012; 191 (03) 317-322
• 5 de Laat MA, Kyaw-Tanner MT, Sillence MN. et al. Advanced glycation endproducts in horses with insulin-induced laminitis. Vet Immunol Immunopathol 2012; 145: 395-401
• 6 Lacombe VA. Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology. ISRN Vet Sci 2014; 2014: 409547
• 7 Henneke DR, Potter GD, Kreider JL. et al. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Vet J 1983; 15 (04) 371-372
• 8 Fitzgerald DM, Anderson ST, Sillence MN. et al. The cresty neck score is an independent predictor of insulin dysregulation in ponies. PLoS One 2019; 14 (07) e0220203
• 9 Durham AE, Frank N, McGowan CM. et al. ECEIM consensus statement on equine metabolic syndrome. J Vet Intern Med 2019; 33 (02) 335-349
• 10 Françoso R, Baccarin RY, de Siqueira RF. et al. Use of FreeStyle Libre for continuous glucose monitoring in adult horses. J Vet Emerg Crit Care (San Antonio) 2024; 34 (02) 123-130
• 11 de Laat MA, Warnken T, Delarocque J. et al. Carbohydrate pellets to assess insulin dysregulation in horses. J Vet Intern Med 2023; 37 (01) 302-314
• 12 Hodge E, Kowalski A, Torcivia C. et al. Effect of thyrotropin-releasing hormone stimulation testing on the oral sugar test in horses when performed as a combined protocol. J Vet Intern Med 2019; 33 (05) 2272-2279
• 13 Dugdale AHA, Curtis GC, Cripps P. et al. Effect of dietary restriction on body condition, composition and welfare of overweight and obese pony mares. Equine Vet J 2010; 42 (07) 600-610 Erratum in: Equine Vet J 2011; 43(1): 121 Erratum in: Equine Vet J 2011; 43(1): 121
• 14 Argo CM, Curtis GC, Grove-White D. et al. Weight loss resistance: a further consideration for the nutritional management of obese Equidae. Vet J 2012; 194 (02) 179-188
• 15 Sundra T, Rossi G, Rendle D. et al. A practical approach to hyperinsulinaemia in horses with equine metabolic syndrome. Equine Vet Educ 2024; 36: 325-336
• 16 Durham AE, Rendle DI, Newton JR. The effect of metformin on measurements of insulin sensitivity and β cell response in 18 horses and ponies with insulin resistance. Equine Vet J 2008; 40 (05) 493-500
• 17 Sundra T, Kelty E, Rendle D. Preliminary observations on the use of ertugliflozin in the management of hyperinsulinaemia and laminitis in 51 horses: A case series. Equine Vet Educ 2023; 35 (06) 311-320
• 18 Kellon EM, Gustafson KM. Use of the SGLT2 inhibitor canagliflozin for control of refractory equine hyperinsulinemia and laminitis. Open Vet J 2022; 12 (04) 511-518
• 19 Meier A, Reiche D, de Laat M. et al. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies. PLoS One 2018; 13 (09) e0203655
• 20 Meier A, de Laat M, Reiche D. et al. The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies. BMC Vet Res 2019; 15 (01) 65
• 21 Rieg T, Masuda T, Gerasimova M. et al. Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia. Am J Physiol Renal Physiol 2014; 306 (02) F188-193
• 22 Sullivan R. Endocrine disease in donkeys. BEVA Congress, 2023: Birmingham (UK), 13.–16. September. Im Internet (Stand: Juni 2024): https://www.thedonkeysanctuary.org.uk/research/paper/3152
• 23 Mendoza FJ, Toribio RE, Perez-Ecija A. Metabolic and Endocrine Insights in Donkeys. Animals (Basel) 2024; 14 (04) 590